Covenant Asset Management’s Boston Scientific BSX Stock Holding History

Covenant Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-39,941	Closed	-$3.81M	–	168
2025 Q4	$3.81M	Sell	39,941 -309	-0.8%	-$30.3K	0.45%	50
2025 Q3	$3.93M	Buy	40,250 +491	+1%	+$50.8K	0.44%	51
2025 Q2	$4.27M	Buy	39,759 +1,051	+3%	+$106K	0.63%	42
2025 Q1	$3.9M	Buy	38,708 +588	+2%	+$59.2K	0.86%	41
2024 Q4	$3.4M	Buy	+38,120	New	+$3.36M	0.52%	55

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Covenant Asset Management's BSX Position: Q1 2026 in Review

Covenant Asset Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 39,941 shares — an estimated $3.81M sold.

Covenant Asset Management first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $4.27M in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Covenant Asset Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Covenant Asset Management sold 39,941 Boston Scientific shares in Q1 2026, an estimated $3.81M.
Covenant Asset Management first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
Covenant Asset Management's Boston Scientific position peaked at $4.27M in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Covenant Asset Management's 13F filing for Q1 2026, filed 14 Apr 2026.